High concentrations of the interleukin-1 receptor antagonist in serum of patients with Hodgkin's disease

The Lancet

Volumn 340, Issue 8825, 1992, Pages 968-

  Gruss, H J ^a   Dolken G ^a   Brach, M A ^a   Mertelsmann, R ^a   Herrmann, F ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; RECEPTOR BLOCKING AGENT;

ADULT; CONTROLLED STUDY; FEMALE; HODGKIN DISEASE; HUMAN; LETTER; MALE; PRIORITY JOURNAL; SERUM;

HODGKIN DISEASE; HUMAN; INTERLEUKIN-1;

EID: 0026787848     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(92)92849-B     Document Type: Letter

References (7)

1. Expression of cytokine genes, cytokine receptor genes, and transcription factors in cultured Hodgkin and Reed-Stemberg cells
2. Interleukin-1 and interleukin-1 antagonism
3. A urine inhibitor of interleukin 1 activity that blocks ligand binding
4. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor
5. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist
6. Interleukin-1 (IL-1) receptor antagonist binds to the 80 kDa IL-1 receptor but does not initiate IL-1 signal transduction
7. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock